Tiziana Life Sciences Ltd
TLSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001723069
In the last 90 days, Tiziana Life Sciences Ltd insiders filed 4 open-market purchases and 0 sales; 30 institutions reported holding it in 13F filings for Q2 2026, worth $3.10M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Tiziana Life Sciences Ltd changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 23 | 23 | 0 |
| Shares | 5.10M | 5.57M | +472.2K (+9.3%) |
| Value | $14.1M | $13.1M | −$1.07M (−7.5%) |
New holders (4)
Institutions that held Tiziana Life Sciences Ltd at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock Inc. | 560,460 | $1.31M | 0.00% |
| D. E. Shaw & Co., Inc. | 16,751 | $39.0K | 0.00% |
| Platform Technology Partners | 10,000 | $23.0K | 0.01% |
| UBS Group AG | 1,278 | $3.00K | 0.00% |
Sold out (4)
Institutions that held Tiziana Life Sciences Ltd at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Wells Fargo & Company | 35,850 | $99.0K |
| Citadel Advisors LLC | 34,687 | $96.0K |
| Legal & General Group Plc | 21,530 | $59.0K |
| QCM Cayman, Ltd. | 10,298 | $29.0K |